Abstract
PURPOSE: Disorder of mucosal immunity based on an imbalance between proinflammatory and anti-inflammatory cytokines is believed to be a major factor in the pathogenesis of ulcerative colitis. Platelet-activating factor potentially stimulates the production of proinflammatory cytokines and recruits inflammatory cells. The aim of this study was to determine whether and to what extent platelet-activating factor plays a role in the pathogenesis of ulcerative colitis. METHODS: Using dextran sulfate sodium-induced colitis in rats as a model of ulcerative colitis, we analyzed the composition of cellular infiltrates and the local tissue expression of messenger ribonucleic acid for cytokine-induced neutrophil chemoattractant and tumor necrosis factor-alpha. To directly assess the impact of platelet-activating factor on the development of colitis, we also determined the efficacy of a specific platelet-activating factor receptor antagonist for preventing dextran sulfate sodium-induced colitis. RESULTS: The activity of colitis was well correlated with the upregulation of cytokine-induced neutrophil chemoattractant and tumor necrosis factor-alpha messenger ribonucleic acid in local tissues and infiltration of cytokine-induced neutrophil chemoattractant-positive neutrophils and ED1-positive macrophages. The platelet-activating factor receptor antagonist effectively ameliorated colitis, along with causing a decrease in the tissue cytokine-induced neutrophil chemoattractant messenger ribonucleic acid level and a decline in neutrophil and macrophage infiltration. However, the antagonist did not alter tissue levels of tumor necrosis factor-alpha messenger ribonucleic acid. CONCLUSION: Platelet-activating factor plays a critical role in the pathogenesis of dextran sulfate sodium-induced colitis through recruitment of cytokine-induced neutrophil chemoattractant-positive neutrophils and macrophages and/or stimulation of cytokine-induced neutrophil chemoattractant release from activated neutrophils. The tissue level of tumor necrosis factor-alpha messenger ribonucleic acid does not closely reflect the activity of colitis.
Similar content being viewed by others
References
C Fiocchi (1998) ArticleTitleInflammatory bowel disease Gastroenterology 115 182–205
WS Selby G Janossy M Bofill DP Jewell (1984) ArticleTitleIntestinal lymphocyte subpopulations in inflammatory bowel disease Gut 25 32–40
H Toyoda SJ Wang HJ Yang et al. (1993) ArticleTitleDistinct associations of HLA class II genes with inflammatory bowel disease Gastroenterology 104 741–748
C Tysk H Riedesen E Lindberg B Panzini D Podolsky G Jarnerot (1991) ArticleTitleColonic glycoproteins in monozygotic twins with inflammatory bowel disease Gastroenterology 100 419–423
T Dohi K Fujihashi H Kiyono CO Elson JR McGhee (2000) ArticleTitleMice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis Gastroenterology 119 724–733
IJ Fuss M Neurath M Boirivant et al. (1996) ArticleTitleDisparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1261–1270
G Roger T Andes (1998) ArticleTitleCytokines in inflammatory bowel disease World J Surg 22 382–389
T Andus SR Taragan R Deem H Toyoda (1993) ArticleTitleMeasurement of tumor necrosis factor α mRNA in small numbers of cells by quantitative polymerase chain reaction Reg Immunol 5 11–17
M Ligumsky PL Simon F Karmeli D Rachmilewitz (1990) ArticleTitleRole of interleukin-1 in inflammatory bowel disease Gut 31 686–689
W Holtkamp T Stollberg HE Reis (1995) ArticleTitleSerum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease J Clin Gastroenterol 20 123–126
R Daig T Andus E Aschenbrenner W Falk J Scholmerich V Gross (1996) ArticleTitleIncreased interleukin-8 expression in the colon mucosa of patients with inflammatory bowel disease Gut 38 216–222
GZ Lotner JM Lynch SJ Betz PM Henson (1980) ArticleTitleHuman neutrophil-derived platelet activating factor J Immunol 124 676–684
M Chignard JP Lecouedic M Tence BB Vargaftig J Benveniste (1979) ArticleTitleThe role of platelet-activating factor in platelet aggregation Nature 279 779–800
Y Hamasaki M Mojara T Saga H Tai SI Said (1984) ArticleTitlePlatelet-activating factor raises airway and vascular pressure and induces edema in lungs perfused with platelet-free solution Am Rev Respir Dis 129 742–746
M Tamm M Bihl O Eickelberg P Stulz AP Perruchoud M Roth (1998) ArticleTitleHypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells Am J Respir Cell Mol Biol 19 653–661
R Guimbaud A Izzo JP Martinolle et al. (1995) ArticleTitleIntraluminal excretion of PAF, LysoPAF, and acetylhydrolase in patients with ulcerative colitis Dig Dis Sci 40 2635–2640
R Eliakim F Karmeli E Razin D Rachmilewitz (1988) ArticleTitleRole of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone Gastroenterology 95 1167–1172
F Capasso IA Tavares A Bennett (1991) ArticleTitleRelease of platelet-activating factor (PAF) from human colon mucosa and its inhibition by 5-aminosalicylic acid Drugs Exp Clin Res 17 351–353
AK Azad Khan J Piris SC Truelove (1977) ArticleTitleAn experiment to determine the active therapeutic moiety of sulphasalazine Lancet 2 892–895
I Okayasu S Hatakeyama M Yamada T Ohkusa Y Inagaki R Nakaya (1990) ArticleTitleA novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 694–702
LA Dieleman BU Ridwan GS Tennyson KW Beagley RP Bucy CO Elson (1994) ArticleTitleDextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice Gastroenterology 107 1643–1652
H Takizawa N Shintani M Natsui et al. (1995) ArticleTitleActivated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506 Digestion 56 259–264
B Egger HV Carey F Procaccino et al. (1998) ArticleTitleReduced susceptibility of mice overexpressing transforming growth factor α to dextran sodium sulfate induced colitis Gut 43 64–70
A Serizawa S Nakamura S Suzuki S Baba M Nakano (1996) ArticleTitleInvolvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion Hepatology 23 1656–1663
T Sakaguchi S Nakamura S Suzuki et al. (1999) ArticleTitleParticipation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats Hepatology 30 959–967
K Watanabe K Konisi M Fujioka S Kinoshita H Nakagawa (1989) ArticleTitleThe neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein J Biol Chem 264 19559–63
RA Siddiqui LP Akard JG Garcia Y Cui D English (1999) ArticleTitleChemotactic migration triggers IL-8 generation in neutrophilic leukocytes J Immunol 162 1077–1083
JT O’Flaherty RL Wykle CH Miller et al. (1981) ArticleTitle1-O-alkyl-sn-glyceryl-3-phosphorycholine Am J Pathol 103 70–79
JA Smith (1994) ArticleTitleNeutrophils, host defense, and inflammation J Leukoc Biol 56 672–686
H Jaeschke CW Smith (1997) ArticleTitleMechanisms of neutrophil-induced parenchymal cell injury J Leukoc Biol 61 647–653
S Denault MJ April J Stañková (1997) ArticleTitleTranscriptional activation of interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes Immunology 91 297–302
F Bussolino M Sironi E Bocchietto A Mantovani (1992) ArticleTitleSynthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8 J Biol Chem 267 14598–603
Y Kawano H Narahara JM Johnston (1999) ArticleTitleInhibitory effect of interleukin-8 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages J Soc Gynecol Invest 6 328–332
KJ Tracey A Cerami (1993) ArticleTitleTumor necrosis factor, other cytokines and disease Annu Rev Cell Biol 9 317–343
P Vassalli (1992) ArticleTitleThe pathophysiology of tumor necrosis factors Annu Rev Immunol 10 411–452
SH Murch CP Braegger JA Walker-Smith TT MacDonald (1993) ArticleTitleLocation of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease Gut 34 1705–1709
M Cappello S Keshav C Prince DP Jewell S Gordon (1992) ArticleTitleDetection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridization Gut 33 1214–1219
F Shanahan (2001) ArticleTitleInflammatory bowel disease Gastroenterology 120 622–635
E Sariban K Imamura R Luebbers D Kufe (1988) ArticleTitleTranscriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes J Clin Invest 81 1506–1510
T Lindsten CH June JA Ledbetter G Stella CB Thompson (1989) ArticleTitleRegulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway Science 244 339–343
J Han B Beutler G Huez (1991) ArticleTitleComplex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages Biochem Biophys Acta 1090 22–28
C Stevens G Walz C Singaram et al. (1992) ArticleTitleTumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease Dig Dis Sci 37 818–826
H Masuda S Iwai T Tanaka S Hayakawa (1995) ArticleTitleExpression of IL-8, TNF-α and IFN-γ m-RNA in ulcerative colitis, particularly in patients with inactive phase J Clin Lab Immunol 46 111–123
G Camussi C Tetta C Baglioni (1990) ArticleTitleThe role of platelet-activating factor in inflammation Clin Immunol Immunopathol 57 331–338
TD Wardle LA Turnberg (1994) ArticleTitlePotential role for interleukin-1 in the pathophysiology of ulcerative colitis Clin Sci 86 619–626
SP Travis B Crotty DP Jewell (1995) ArticleTitleSite of action of platelet-activating factor within the mucosa of rabbit distal colon Clin Sci 88 51–57
M Mahler IJ Bristol EH Leiter et al. (1998) ArticleTitleDifferential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis Am J Physiol 274 544–551
H Wang X Tan H Chang F Gonzales-Crussi DG Remick W Hsueh (1997) ArticleTitleRegulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor Biochem J 322 603–608
Author information
Authors and Affiliations
About this article
Cite this article
Hirayama, K., Yokoi, Y., Sakaguchi, T. et al. Platelet-Activating Factor, a Critical Mediator in the Pathogenesis of Dextran Sulfate Sodium-Induced Colitis in Rats. Dis Colon Rectum 46, 100–110 (2003). https://doi.org/10.1007/s10350-004-6503-7
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-6503-7